share_log

JMP Securities Maintains Market Outperform on Relay Therapeutics, Lowers Price Target to $21

JMP Securities Maintains Market Outperform on Relay Therapeutics, Lowers Price Target to $21

JMP证券维持对relay therapeutics的市场超额表现评级,将价格目标下调至21美元。
Benzinga ·  07/18 07:27

JMP Securities analyst Silvan Tuerkcan maintains Relay Therapeutics (NASDAQ:RLAY) with a Market Outperform and lowers the price target from $24 to $21.

JMP Securities分析师西尔文·图尔克坎维持Relay Therapeutics(纳斯达克股票代码:RLAY)的市场跑赢大盘,并将目标股价从24美元下调至21美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发